梯瓦制药Teva Pharmaceutical Industries Limited (TEVA) 2014年CSR报告「NYSE」.pdf

1、Teva 2014 Global Citizenship ReportInnovating for Better HealthABOUT TEVATeva at a glanceMessage from our President and CEO:Erez VigodmanCitizenship at Teva2014 citizenship highlightsA European perspective on generic medicineInnovating for Better HealthAffordable healthcareIntegrated healthcare inno

2、vationBio-medical research excellencePatient safetyPatient supportResponsible Business ConductEthical standardsEnvironment and safetyEHS strategyEnergy and emissions managementEnvironmental performanceGood environmental practice from around TevaOccupational health and safety performanceExcellence aw

3、ards for safe operationsEmployee engagementCommunity solidarityGovernance and reportingGovernance,compliance and risk managementAbout this reportUNGC PrinciplesGRI Content IndexTable of contents33567101116273037434448505253545557586671727677789About TevaTeva 2014 Global Citizenship ReportEstablished

4、 in 1901,Teva Pharmaceutical Industries Ltd.is today a leading global pharmaceutical company.We deliver high-quality,healthcare solutions for millions of patients every day.Headquartered in Israel,Teva is the worlds largest generic medicines producer,leveraging a portfolio of more than 1,000 molecul

5、es to produce generic products in nearly every major therapeutic area.In specialty medicines,we have a world-leading position in innovative treatments for disorders of the Central Nervous System,including pain and migraine,as well as a strong portfolio of respiratory products.We integrate our generi

6、cs and specialty capabilities in our global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices,services and technologies.Our net revenues in 2014 amounted to$20.3 billion,we employ 43,000 people and deliver m